Skip to main content

PMV Pharmaceuticals, Inc.

PMVP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001699382

No open-market purchases or sales by PMV Pharmaceuticals, Inc. insiders were filed in the last 90 days; 64 institutions reported holding it in 13F filings for Q2 2026, worth $45.9M in total; no superinvestor holds it.

Superinvestors holding PMVP, Q2 2026

See all superinvestors

No superinvestor reported holding PMVP in Q2 2026.

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of PMVP each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q2 2022

    0 superinvestors holding at quarter end

    Sold out
    Viking Global Investors
  2. Q1 2022

    1 superinvestor holding at quarter end

    Reduced
    Viking Global Investors (−39.9%)
  3. Q2 2021

    1 superinvestor holding at quarter end

    Reduced
    Viking Global Investors (−14.2%)